BR9711311A - Composto composi-Æo farmac-utica uso de um composto e processos para a prepara-Æo de compostos e para tratamento de um mamifero incluindo o homem - Google Patents
Composto composi-Æo farmac-utica uso de um composto e processos para a prepara-Æo de compostos e para tratamento de um mamifero incluindo o homemInfo
- Publication number
- BR9711311A BR9711311A BR9711311A BR9711311A BR9711311A BR 9711311 A BR9711311 A BR 9711311A BR 9711311 A BR9711311 A BR 9711311A BR 9711311 A BR9711311 A BR 9711311A BR 9711311 A BR9711311 A BR 9711311A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- compounds
- processes
- preparation
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9617305.9A GB9617305D0 (en) | 1996-08-17 | 1996-08-17 | Heterocyclic compounds |
PCT/EP1997/004440 WO1998007704A1 (en) | 1996-08-17 | 1997-08-14 | Tetrahydroquinoline derivatives as eaa antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9711311A true BR9711311A (pt) | 1999-08-17 |
BR9711311B1 BR9711311B1 (pt) | 2009-01-13 |
Family
ID=10798623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9711311-5A BR9711311B1 (pt) | 1996-08-17 | 1997-08-14 | derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos. |
Country Status (34)
Country | Link |
---|---|
US (1) | US6479488B1 (pt) |
EP (1) | EP0922034B1 (pt) |
JP (1) | JP4108129B2 (pt) |
KR (1) | KR100552864B1 (pt) |
CN (1) | CN1131214C (pt) |
AP (1) | AP877A (pt) |
AR (1) | AR008296A1 (pt) |
AT (1) | ATE221052T1 (pt) |
AU (1) | AU724473B2 (pt) |
BR (1) | BR9711311B1 (pt) |
CA (1) | CA2264118C (pt) |
CO (1) | CO4900066A1 (pt) |
CZ (1) | CZ296250B6 (pt) |
DE (1) | DE69714265T2 (pt) |
DK (1) | DK0922034T3 (pt) |
EA (1) | EA001704B1 (pt) |
ES (1) | ES2181030T3 (pt) |
GB (1) | GB9617305D0 (pt) |
HU (1) | HU225797B1 (pt) |
ID (1) | ID18095A (pt) |
IL (1) | IL128141A0 (pt) |
IS (1) | IS4953A (pt) |
MY (1) | MY116952A (pt) |
NO (1) | NO312241B1 (pt) |
NZ (1) | NZ333812A (pt) |
PE (1) | PE107098A1 (pt) |
PL (1) | PL194532B1 (pt) |
PT (1) | PT922034E (pt) |
SI (1) | SI0922034T1 (pt) |
TR (1) | TR199900336T2 (pt) |
TW (1) | TW449582B (pt) |
WO (1) | WO1998007704A1 (pt) |
YU (1) | YU6799A (pt) |
ZA (1) | ZA977326B (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9706294D0 (en) * | 1997-03-26 | 1997-05-14 | Glaxo Wellcome Spa | Heterocyclic compound |
MY125037A (en) | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
US6455734B1 (en) | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
GB9929037D0 (en) | 1999-12-08 | 2000-02-02 | Glaxo Wellcome Spa | Heterocyclic derivatives |
DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
IL162616A0 (en) * | 2001-12-28 | 2005-11-20 | Acadia Pharm Inc | Tetrahydroquinoline analogues as muscarinic agonists |
US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
US20050085463A1 (en) * | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
JP2006515628A (ja) * | 2003-01-23 | 2006-06-01 | アカディア ファーマシューティカルズ,インコーポレーテッド | ヒト神経精神疾患を処置するためのn−デスメチルクロザピンの使用 |
WO2004073639A2 (en) * | 2003-02-19 | 2004-09-02 | Merck & Co. Inc. | Treatment of psychosis with a muscarinic m1 receptor ectopic activator |
SG133606A1 (en) * | 2003-12-22 | 2007-07-30 | Acadia Pharm Inc | Amino substituted diaryl [a,d] cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
CA2560671A1 (en) * | 2004-04-01 | 2006-01-05 | Acadia Pharmaceuticals Inc. | Crystalline forms of n-desmethylclozapine |
PT1908753E (pt) * | 2005-07-22 | 2015-02-06 | Mochida Pharm Co Ltd | Novo derivado acetamida de heterociclideno |
RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
WO2007033082A2 (en) * | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
CA2622204C (en) | 2005-09-12 | 2016-10-11 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same |
US20070105836A1 (en) * | 2005-10-31 | 2007-05-10 | Lars Pettersson | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
JP5947721B2 (ja) | 2009-10-30 | 2016-07-06 | アベラ ファーマスーティカルズ インコーポレイテッド | 変形性関節症を治療するためのジメチルスルホキシド(dmso)およびメチルスルホニルメタン(msm)製剤 |
CA2850707C (en) | 2011-10-03 | 2023-03-21 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE147732T1 (de) * | 1989-03-08 | 1997-02-15 | Merck Sharp & Dohme | Tetrahydroquinolin-derivate, verwendbar bei neurodegenerativen krankheiten |
PL186781B1 (pl) | 1995-09-29 | 2004-02-27 | Glaxo Wellcome Spa | Nowy związek, pochodna tetrahydrochinoliny, sposób wytwarzania pochodnej tetrahydrochinoliny, środek farmaceutyczny i zastosowanie |
-
1996
- 1996-08-17 GB GBGB9617305.9A patent/GB9617305D0/en active Pending
-
1997
- 1997-08-14 DE DE69714265T patent/DE69714265T2/de not_active Expired - Lifetime
- 1997-08-14 PE PE1997000718A patent/PE107098A1/es not_active Application Discontinuation
- 1997-08-14 WO PCT/EP1997/004440 patent/WO1998007704A1/en active IP Right Grant
- 1997-08-14 ES ES97943809T patent/ES2181030T3/es not_active Expired - Lifetime
- 1997-08-14 ID IDP972834A patent/ID18095A/id unknown
- 1997-08-14 DK DK97943809T patent/DK0922034T3/da active
- 1997-08-14 YU YU6799A patent/YU6799A/sh unknown
- 1997-08-14 CN CN97197233A patent/CN1131214C/zh not_active Expired - Fee Related
- 1997-08-14 CZ CZ0052999A patent/CZ296250B6/cs not_active IP Right Cessation
- 1997-08-14 EA EA199900121A patent/EA001704B1/ru not_active IP Right Cessation
- 1997-08-14 MY MYPI97003742A patent/MY116952A/en unknown
- 1997-08-14 AU AU45518/97A patent/AU724473B2/en not_active Ceased
- 1997-08-14 JP JP51037298A patent/JP4108129B2/ja not_active Expired - Fee Related
- 1997-08-14 PL PL97331562A patent/PL194532B1/pl not_active IP Right Cessation
- 1997-08-14 CO CO97046782A patent/CO4900066A1/es unknown
- 1997-08-14 EP EP97943809A patent/EP0922034B1/en not_active Expired - Lifetime
- 1997-08-14 BR BRPI9711311-5A patent/BR9711311B1/pt not_active IP Right Cessation
- 1997-08-14 PT PT97943809T patent/PT922034E/pt unknown
- 1997-08-14 HU HU9903108A patent/HU225797B1/hu not_active IP Right Cessation
- 1997-08-14 ZA ZA977326A patent/ZA977326B/xx unknown
- 1997-08-14 KR KR1019997001280A patent/KR100552864B1/ko not_active IP Right Cessation
- 1997-08-14 TR TR1999/00336T patent/TR199900336T2/xx unknown
- 1997-08-14 AT AT97943809T patent/ATE221052T1/de not_active IP Right Cessation
- 1997-08-14 US US09/147,568 patent/US6479488B1/en not_active Expired - Fee Related
- 1997-08-14 SI SI9730404T patent/SI0922034T1/xx unknown
- 1997-08-14 NZ NZ333812A patent/NZ333812A/xx active Application Revival
- 1997-08-14 AR ARP970103703A patent/AR008296A1/es active IP Right Grant
- 1997-08-14 CA CA002264118A patent/CA2264118C/en not_active Expired - Fee Related
- 1997-08-14 AP APAP/P/1999/001459A patent/AP877A/en active
- 1997-08-14 IL IL12814197A patent/IL128141A0/xx not_active IP Right Cessation
- 1997-08-30 TW TW086112442A patent/TW449582B/zh not_active IP Right Cessation
-
1999
- 1999-01-22 IS IS4953A patent/IS4953A/is unknown
- 1999-02-16 NO NO19990723A patent/NO312241B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9711311A (pt) | Composto composi-Æo farmac-utica uso de um composto e processos para a prepara-Æo de compostos e para tratamento de um mamifero incluindo o homem | |
BR9602705A (pt) | Composto composição farmacéutica processo para a preparação de um composto e uso | |
BR9610248A (pt) | Composto composição farmacêutica processos para o tratamento da dor e para a preparação de um composto e uso do composto | |
BR9609780A (pt) | Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto | |
BR9609467A (pt) | Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária | |
BR9505107A (pt) | Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso | |
BR9609701A (pt) | Composição farmacéutica composto e processo para a preparação de compostos | |
BR9507656A (pt) | Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto | |
BR9707501A (pt) | Composto composição farmacêutica e uso do composto | |
BR1100850A (pt) | Composto, processo para a preparação de um composto, e, composição farmacêutica | |
BR9406128A (pt) | Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica | |
BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
BR1100323A (pt) | Composto, uso de um composto, composição farmacêutica e processo para preparar um composto | |
BR9706311A (pt) | Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética | |
BR9607346A (pt) | Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos | |
BR9506473A (pt) | Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas | |
BR9610733A (pt) | Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto | |
BR9708014A (pt) | Derivados de arilglicinamida processo para a preparação deles e composições farmacêuticas contendo estes compostos | |
BR9505610A (pt) | Composto composição farmacéutica processo para a preparação de um composto uso e método de tratar inflamação e dor | |
BR9707808A (pt) | Composto composição farmacêutica e uso do composto | |
BR9607095A (pt) | Composto composição farmacêutica e processos para fabricar e para administrar um composto | |
BR9600688A (pt) | Compostos heterocíclicos aromáticos composição farmacêutica uso de um composto e composição cosmética | |
BR9708790A (pt) | Composto uso de um composto e formulação farmacêutica | |
BR9600339A (pt) | Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos | |
BR9611234A (pt) | Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: C07D 215/48, A61K 31/47, A61P 25/28, A61P 43/00 Ipc: C07D 215/48 (2007.10), A61K 31/47 (2007.10), A61P |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/01/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
B24C | Patent annual fee: request for for restoration |
Free format text: REFERENTE AS 14A E 15A ANUIDADES. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2197 DE 13/02/2013 E AO NAO RECOLHIMENTO DA 16A ANUIDADE. |